Arkolith/Insider Trading/NBRV/Form 4

Burgess Daniel D

DirectorNabriva Therapeutics plc (NBRV) · full profile →Form 4 · filed Aug 4, 2022
Net Selling
Open-Market Buys
$0
Open-Market Sells
$2K
Net Open-Market Flow
-$2K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 2, 2022Sell(S)11K$0.19$2K10K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-22-086282) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML